Showing posts with label scientific library. Show all posts
Showing posts with label scientific library. Show all posts

Saturday, April 25, 2026

#Coronavirus Disease Research #References (by AMEDEO, April 25 '26)

 


    Ann Intern Med

  1. FRITZ JM, Skolasky RL, Brennan G, Minick K, et al
    Effectiveness of Nonpharmacologic Treatments for Chronic Low Back Pain : A Sequential, Multiple-Assignment, Randomized Trial.
    Ann Intern Med. 2026 Apr 21. doi: 10.7326/ANNALS-25-04645.
    PubMed         Abstract available


    Clin Infect Dis

  2. BAKER JV, Siegel L, Losso M, Vasudeva S, et al
    Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trial.
    Clin Infect Dis. 2026 Apr 22:ciag272. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis

  3. ZHAO CY, Wang FS, Jiao YM
    SARS-CoV-2 infection disrupts the immune control status in a male HIV-1 elite controller.
    Int J Infect Dis. 2026 Apr 20:108713. doi: 10.1016/j.ijid.2026.108713.
    PubMed         Abstract available


    J Infect

  4. BEHARIER O, Guedalia J, Sehtman-Shachar DR, Kerem L, et al
    Maternal SARS-CoV-2 Infection and Early Child Growth and Development: A Nationwide Cohort Study.
    J Infect. 2026 Apr 17:106749. doi: 10.1016/j.jinf.2026.106749.
    PubMed         Abstract available


    J Med Virol

  5. HO SY, Liu YC, Ho SY, Chen SH, et al
    Emergence of Echovirus 11 in Severe and Neonatal Enterovirus Infections: A 9-Year Retrospective Study in Taiwan Before and After the COVID-19 Pandemic.
    J Med Virol. 2026;98:e70929.
    PubMed         Abstract available

  6. AVILA JP, Park P, Singh Y, Amaral PP, et al
    Multiorgan Molecular Landscape of Severe COVID-19 Revealed by Consensus Gene Signatures and RAB8B Targeting.
    J Med Virol. 2026;98:e70932.
    PubMed         Abstract available

  7. KESKIN S, Pavel STI, Sak R, Bahadori F, et al
    Modified mRNA Encoding the Crimean-Congo Hemorrhagic Fever Virus Nucleocapsid Protein Confers Robust Protection Against Lethal Challenge in Mice.
    J Med Virol. 2026;98:e70940.
    PubMed         Abstract available


    J Virol

  8. SALISCH F, Muller-Ruttloff C
    Behind the membranous curtain-lipid dynamics and functions in coronaviral replication.
    J Virol. 2026 Apr 21:e0175325. doi: 10.1128/jvi.01753.
    PubMed         Abstract available

  9. YANG M, Zhao Y, Guo W, Wang L, et al
    Development of a vaccine based on mRNA assembly of PEDV virus-like particle.
    J Virol. 2026 Apr 21:e0206025. doi: 10.1128/jvi.02060.
    PubMed         Abstract available

  10. ZHANG K, Wang S, Kang X, Li F, et al
    Swine GBP1 restricts PDCoV replication via disrupting the replication and transcription complex formation.
    J Virol. 2026 Apr 21:e0020726. doi: 10.1128/jvi.00207.
    PubMed         Abstract available

  11. ZHAO J, Tian J, Zhang L, Li Y, et al
    Coronavirus infectious bronchitis virus spike protein inhibits FUNDC1-mediated mitophagy to prevent nucleocapsid protein degradation.
    J Virol. 2026 Apr 20:e0180025. doi: 10.1128/jvi.01800.
    PubMed         Abstract available

  12. MU S, Bai Y, Qiu R, Zhang F, et al
    Porcine hemagglutinating encephalomyelitis virus nucleocapsid protein targets RIG-I and IRF3 to evade IFN immunity.
    J Virol. 2026 Mar 30:e0211225. doi: 10.1128/jvi.02112.
    PubMed         Abstract available

  13. ZHANG X, Li Y, Yuan J, Li Q, et al
    Metformin hydrochloride regulates glycolysis and inhibits PEDV replication by inhibition of PI3K-AKT signaling pathway.
    J Virol. 2026;100:e0014726.
    PubMed         Abstract available


    JAMA

  14. LEFF B, Siu A, DeCherrie LV, Levine DM, et al
    Hospital at Home and Transforming US Health Care Delivery.
    JAMA. 2026 Apr 23. doi: 10.1001/jama.2026.4791.
    PubMed        

  15. KUKOYI OM, Wang VS, Yao K, Cipriano CB, et al
    US State Actions Related to COVID-19 Vaccination Infrastructure and Access Amid Federal Shifts.
    JAMA. 2026 Apr 20:e265148. doi: 10.1001/jama.2026.5148.
    PubMed        


    Lancet Infect Dis

  16. ZHANG L, Hoffmann M, Pohlmann S
    Does BA.3.2 epidemiology imply a change in SARS-CoV-2 evolution?
    Lancet Infect Dis. 2026 Apr 17:S1473-3099(26)00192.
    PubMed        


    N Engl J Med

  17. BUTLER CC, Pinto AD, Harris V, Holmes J, et al
    Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.
    N Engl J Med. 2026;394:1583-1594.
    PubMed         Abstract available


    Nature

  18. GALLO G, Di Nardo A, Lugano D, Roberts AJ, et al
    Heart-nosed bat alphacoronaviruses use human CEACAM6 to enter cells.
    Nature. 2026 Apr 22. doi: 10.1038/s41586-026-10394.
    PubMed         Abstract available

  19. YAN H
    A bat coronavirus can enter human cells through a previously unknown gateway.
    Nature. 2026 Apr 22. doi: 10.1038/d41586-026-00908.
    PubMed        

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, April 25 '26)

 


    Ann Intern Med

  1. LIM SY, Lee J, Chang E, Kwon JS, et al
    Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19 : A Randomized Clinical Trial.
    Ann Intern Med. 2026 Mar 3. doi: 10.7326/ANNALS-25-04883.
    PubMed         Abstract available

  2. QASEEM A, Obley AJ, Yost J, Abraham GM, et al
    Outpatient Treatment of Confirmed COVID-19 in Symptomatic Adults: Living, Rapid Practice Points From the American College of Physicians (Version 3).
    Ann Intern Med. 2026 Feb 10. doi: 10.7326/ANNALS-25-03766.
    PubMed         Abstract available

  3. SOMMER I, Dobrescu A, Gadinger A, Sharifan A, et al
    Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Review for the American College of Physicians (Version 3).
    Ann Intern Med. 2026 Feb 10. doi: 10.7326/ANNALS-25-03691.
    PubMed         Abstract available


    Biochemistry

  4. MEDEIROS-SILVA J, Zhang Y, Hong M
    Phosphatidylinositol Interactions with the SARS-CoV-2 Envelope Protein Investigated by Lipid (13)C Labeling and Solid-State NMR.
    Biochemistry. 2026;65:1178-1191.
    PubMed         Abstract available


    J Infect

  5. COX SN, Bennett JC, Casto AM, Hoffman KL, et al
    INFLUENZA HOUSEHOLD TRANSMISSION AND GENOMIC DIVERSITY IN THE UNITED STATES: A PROSPECTIVE COHORT STUDY, 2022-2024.
    J Infect. 2026 Apr 20:106748. doi: 10.1016/j.jinf.2026.106748.
    PubMed         Abstract available


    J Virol

  6. ZHANG R, Jian X, Zhang Y, Sun Y, et al
    The oral nucleoside analogue inhibitor VV251 effectively inhibits coinfection by respiratory syncytial virus and influenza A virus.
    J Virol. 2026 Apr 21:e0000626. doi: 10.1128/jvi.00006.
    PubMed         Abstract available

  7. YILDIZ S, El Zahed SS, Villalon-Letelier F, Wang Q, et al
    Re-engineering segment 8 facilitates generation of a versatile live-attenuated influenza A virus vector platform for secretory protein delivery.
    J Virol. 2026 Apr 21:e0034726. doi: 10.1128/jvi.00347.
    PubMed         Abstract available

  8. KONG W, Zhang J, Song Y, Song J, et al
    Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    J Virol. 2026 Mar 30:e0027026. doi: 10.1128/jvi.00270.
    PubMed         Abstract available

  9. XIU R, Wang Y, Cai W, Wang Q, et al
    Potent in vitro synergistic antiviral effects of the pan-coronavirus fusion inhibitor EK1 in combination with RBD-specific antibodies or M(pro) inhibitors.
    J Virol. 2026 Mar 30:e0007626. doi: 10.1128/jvi.00076.
    PubMed         Abstract available

  10. BRENNAN JW, Wang G, Connor S, Wang X, et al
    A respiratory syncytial virus trailer sequence modulates viral replication and the generation and propagation kinetics of copy-back defective viral genomes.
    J Virol. 2026;100:e0018426.
    PubMed         Abstract available

  11. ADAM A, Wu W, Jones MC, Hao H, et al
    Respiratory syncytial virus infection induces heterologous protection against SARS-CoV-2 through gammadelta T cell-mediated trained immunity and the activation of SARS-CoV-2-reactive mucosal T cells.
    J Virol. 2026 Mar 18:e0165825. doi: 10.1128/jvi.01658.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  12. BELL JM, Barbre K, Meng L, Lape-Newman B, et al
    Influenza Vaccination Coverage Among Nursing Home Residents and Health Care Personnel - United States, 2024-25 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2026;75:195-201.
    PubMed         Abstract available


    N Engl J Med

  13. BUTLER CC, Pinto AD, Harris V, Holmes J, et al
    Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.
    N Engl J Med. 2026;394:1583-1594.
    PubMed         Abstract available


    Pediatrics

  14. SEGEV N, Wilson E, Moehlman M, Corathers SD, et al
    Unmasking Adrenal Insufficiency: Adrenal Crisis Triggered by Influenza-Associated Encephalitis.
    Pediatrics. 2026 Apr 22:e2025072983. doi: 10.1542/peds.2025-072983.
    PubMed         Abstract available


    PLoS Comput Biol

  15. LI Y, Nielsen BF, Levin SA, Te Velthuis AJW, et al
    Spatio-temporal modelling of in vitro influenza A virus infection: The impact of defective interfering particles on the type I interferon response.
    PLoS Comput Biol. 2026;22:e1014198.
    PubMed         Abstract available

  16. WHITE LA, Leon TM
    Forecastability of infectious disease time series: are some seasons and pathogens intrinsically more difficult to forecast?
    PLoS Comput Biol. 2026;22:e1014175.
    PubMed         Abstract available


    PLoS One

  17. ORTEGA-MARTIN E, Alvarez-Galvez J
    Understanding quality-of-life patterns in long COVID: How Symptoms and socioeconomic conditions shape patient wellbeing.
    PLoS One. 2026;21:e0347743.
    PubMed         Abstract available

  18. CHAVES SS, Castells VB, Mira-Iglesias A, Puig-Barbera J, et al
    Rhinovirus/enterovirus contribution to respiratory-associated hospitalizations in adults during respiratory seasons in Spain: A 6-year prospective study.
    PLoS One. 2026;21:e0347659.
    PubMed         Abstract available

  19. LEE J, Bajiya VP, Jung E
    Vaccination scenario-based study on seasonal influenza in Republic of Korea.
    PLoS One. 2026;21:e0322686.
    PubMed         Abstract available

  20. PIRZADA P, Wilde A, Doherty GH, Harris-Birtill D, et al
    Understanding older adults' perception, acceptance, and adoption of smart home technologies.
    PLoS One. 2026;21:e0345563.
    PubMed         Abstract available

  21. FANG Z, Xu H, Mu Y
    Risk-taking responses to crash experience: Evidence from China.
    PLoS One. 2026;21:e0347543.
    PubMed         Abstract available

  22. GARZA J, Sebastian R, Cover B, Sanchez A, et al
    Nicotine dependence among critically ill COVID-19 patients: A population-based cohort study.
    PLoS One. 2026;21:e0308776.
    PubMed         Abstract available

  23. MCDONALD C, Grajales AG, Yahia NA, Fisman D, et al
    Healthcare resource utilization and cost burden of COVID-19 according to vaccination status in adults in Ontario, Canada, 2021-2023.
    PLoS One. 2026;21:e0344690.
    PubMed         Abstract available

  24. LOVATO N, Appleton SL, Reynolds AC, Gill TK, et al
    Relationships between pre-pandemic mental health, sociodemographic factors and health behaviours in older adults during the acute onset of COVID-19 in Australia: A descriptive analysis.
    PLoS One. 2026;21:e0346787.
    PubMed         Abstract available

  25. AUDUREAU E, Jean C, Layese R, Neuraz A, et al
    Association between parenthood and survival among 30,386 patients hospitalized with COVID-19.
    PLoS One. 2026;21:e0346679.
    PubMed         Abstract available

  26. IPEKCI AM, Hodel EM, Filsinger M, Wegmuller S, et al
    Who would take part in a pandemic preparedness cohort study? The role of vaccine-related affective polarisation: Cross-sectional survey.
    PLoS One. 2026;21:e0346420.
    PubMed         Abstract available

  27. YANG Z, Imouza A, Puelma Touzel M, Amadoro C, et al
    Regional and temporal patterns of partisan polarization during the COVID-19 pandemic in the United States and Canada.
    PLoS One. 2026;21:e0347327.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  28. SANDERS CG, Liu M, Fusco JA, Ohl EM, et al
    Efficient replication of influenza D virus in the human airway underscores zoonotic potential.
    Proc Natl Acad Sci U S A. 2026;123:e2530325123.
    PubMed         Abstract available


    Vaccine

  29. ROBERTSON AH, Wolf AS, Fossum E, Solum G, et al
    Long-lasting cross-reactive and polyfunctional SARS-CoV-2 T cell responses in seniors are maintained after repeated vaccination and infections.
    Vaccine. 2026;80:128511.
    PubMed         Abstract available

  30. DLOUHY P, Petras M, Lesna IK, Macalik R, et al
    Transient elevation of NT-proBNP after mRNA COVID-19 vaccination in healthy adults: A longitudinal biomarker analysis.
    Vaccine. 2026;80:128535.
    PubMed         Abstract available

  31. VAN DE BURGWAL LHM, Pronker ES, Herz J
    Australia's vaccine legacy: Time for a boost? Mapping an innovation system in a fragmented data environment.
    Vaccine. 2026;80:128525.
    PubMed         Abstract available

  32. WU D, Liu K
    Cost and effectiveness of COVID-19 vaccination strategies during the 2023 post-reopening omicron wave in Xinjiang, Western China: Evidence from SIR and Markov models.
    Vaccine. 2026;80:128536.
    PubMed         Abstract available

  33. MAEDA H, Saito N, Igarashi A, Ishida M, et al
    Effectiveness of JN.1-adapted COVID-19 vaccine against medically attended SARS-CoV-2 infection and COVID-19 hospitalization in adults in Japan, from October 2024 to April 2025: VERSUS.
    Vaccine. 2026;80:128544.
    PubMed         Abstract available

  34. MORO PL, Romanson B, Marquez P, Zhang B, et al
    Adverse events after Pfizer's Respiratory Syncytial Virus Vaccine in pregnant women in the Vaccine Adverse Event Reporting System, 2024-2025, United States.
    Vaccine. 2026;80:128547.
    PubMed         Abstract available

  35. QUINTANAR-SOLARES M, Fleming JA, Musau W, Mulati F, et al
    RSV ready? Exploring feasibility and acceptability of RSV immunization options in low- and middle-income countries.
    Vaccine. 2026;80:128550.
    PubMed         Abstract available

  36. KITANO T, Hashimoto E, Sado T, Yoshida S, et al
    Maternal effectiveness of respiratory syncytial virus using multicenter healthcare records: A retrospective cohort study.
    Vaccine. 2026;80:128566.
    PubMed         Abstract available

  37. ZHANG L, Lin T, Wang M, Ma X, et al
    Effectiveness of prescription-based influenza vaccination services among older adults in Binzhou, China: A cluster-randomized controlled trial.
    Vaccine. 2026;82:128588.
    PubMed         Abstract available

  38. FOLEGATTI PM, Pepin S, Tabar C, Fries K, et al
    Immunogenicity and safety of recombinant influenza vaccine versus standard inactivated influenza vaccine in children aged 3 to 8 years: results from a phase III randomised study.
    Vaccine. 2026;82:128582.
    PubMed         Abstract available

  39. RICE E, Cheng AC, Britton PN, Carr J, et al
    Influenza epidemiology, treatment and prevention in Australian children: Trends from 6 years of PAEDS-FluCAN influenza surveillance (2019-2024).
    Vaccine. 2026;82:128592.
    PubMed         Abstract available

Sunday, April 19, 2026

#Coronavirus Disease Research #References (by AMEDEO, April 19 '26)

 


    Ann Intern Med

  1. ALBALOUL H, Nemer A, Saini N, Schuster MG, et al
    Infectious Diseases: What You May Have Missed in 2025.
    Ann Intern Med. 2026 Apr 14:e2600983. doi: 10.7326/ANNALS-26-00983.
    PubMed         Abstract available


    BMJ

  2. DAVIES SR, Davies AL, Higgins JPT, Caldwell DM, et al
    Effectiveness of interventions to increase vaccine uptake: component network meta-analysis.
    BMJ. 2026;393:e087578.
    PubMed         Abstract available

  3. PAGEL C
    The UK Covid-19 Inquiry lays bare the cost of delayed action for NHS staff.
    BMJ. 2026;393:s696.
    PubMed        


    Clin Infect Dis

  4. THORPE A, Lee RA, Szymczak JE, Farrell MC, et al
    Comparing the Antimicrobial Resistance Crisis to the Coronavirus Disease 2019 Pandemic: A Randomized Public Health Messaging Experiment.
    Clin Infect Dis. 2026 Apr 8:ciag110. doi: 10.1093.
    PubMed         Abstract available


    Emerg Infect Dis

  5. ISMAIL H, Perovic O, Mpembe R, Lowman W, et al
    Accelerated Increase in Candida auris Bloodstream Infections during COVID-19 Pandemic, South Africa.
    Emerg Infect Dis. 2026;32:563-572.
    PubMed         Abstract available

  6. ANDRES C, Prats-Mendez I, Midgley S, Berginc N, et al
    Circulation Patterns, Genetic Diversity, and Public Health Implications of Enterovirus D68, Europe, 2014-2024.
    Emerg Infect Dis. 2026;32:491-499.
    PubMed         Abstract available


    Infect Control Hosp Epidemiol

  7. DUROCHER F, Dufresne SF, Dufresne PJ, Marchand-Senecal X, et al
    Healthcare-associated Pneumocystis jirovecii transmission in the era of universal masking and distancing.
    Infect Control Hosp Epidemiol. 2026 Apr 13:1-6. doi: 10.1017/ice.2026.10446.
    PubMed         Abstract available


    Int J Infect Dis

  8. NGIAM JN, Yap AJ, Wee LE, Koh MCY, et al
    Parental Vaccination Status and Other Socioeconomic Determinants Shaping COVID-19 Vaccine Uptake in Children and Adolescents in Singapore.
    Int J Infect Dis. 2026 Apr 15:108686. doi: 10.1016/j.ijid.2026.108686.
    PubMed         Abstract available

  9. ALI AS, Vanoli E, Smati-Lafarge M, Boudjemaa A, et al
    Computational Fluid Dynamics and Genotyping to explore Airborne Transmission of Respiratory Viruses in Hospitals.
    Int J Infect Dis. 2026 Apr 9:108697. doi: 10.1016/j.ijid.2026.108697.
    PubMed         Abstract available

  10. GARDINER LE, Lozano-Rojas D, Smith N, Espley J, et al
    Investigating prognostic classifications of pre-existing multiple long-term conditions for health outcomes one-year after COVID-19 hospitalisation: a UK prospective observational study.
    Int J Infect Dis. 2026 Apr 9:108695. doi: 10.1016/j.ijid.2026.108695.
    PubMed         Abstract available


    Intensive Care Med

  11. MYATRA SN, Nasa P, Chanchalani GP, Zimmerman JL, et al
    Gender equality and equity in intensive care: an international Delphi consensus study.
    Intensive Care Med. 2026 Apr 15. doi: 10.1007/s00134-026-08394.
    PubMed         Abstract available


    J Med Virol

  12. MULLER V, Kolditz M, Shvachko V, Oppelt T, et al
    Effectiveness of Remdesivir on All-Cause In-Hospital Mortality in Patients With Chronic Respiratory Comorbidities Who Are Hospitalized With COVID-19 in the United States.
    J Med Virol. 2026;98:e70926.
    PubMed         Abstract available

  13. CAPPARELLI E, Maggiolini D, Paschale M, Pavia C, et al
    Changes in ANA Positivity Following SARS-CoV-2 Outbreak in Lombardy Region, Italy.
    J Med Virol. 2026;98:e70927.
    PubMed         Abstract available


    J Virol

  14. RAHEJA H, Sahu R, Ghosh T, Paul S, et al
    HuR enhances SARS-CoV-2 non-structural protein translation through the genomic 5'-UTR, by promoting polypyrimidine tract-binding protein binding.
    J Virol. 2026 Apr 16:e0027626. doi: 10.1128/jvi.00276.
    PubMed         Abstract available


    JAMA

  15. RUBIN R
    What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring.
    JAMA. 2026 Apr 17. doi: 10.1001/jama.2026.5535.
    PubMed        


    Life Sci

  16. BARTOLOMEO CS, Lemes RMR, Morais RL, Pereria GC, et al
    Corrigendum to "SARS-CoV-2 infection and replication kinetics in different human cell types: The role of autophagy, cellular metabolism and ACE2 expression" [Life Sciences 308 (2022) 120930].
    Life Sci. 2026 Apr 9:124367. doi: 10.1016/j.lfs.2026.124367.
    PubMed        


    Nat Ment Health

  17. HIDALGO-PADILLA L, Gogarty E, Sarkodie R, Gaughran F, et al
    Primary care consultation modality and acute mental health service use in adults.
    Nat Ment Health. 2026;4:574-581.
    PubMed         Abstract available


    Nature

  18. STEINER C
    Almost half of traded wildlife carries disease-causing pathogens.
    Nature. 2026 Apr 9. doi: 10.1038/d41586-026-01121.
    PubMed        

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, April 19 '26)

 


    Biochem Biophys Res Commun

  1. CHEN M, Chen W, Jiang X, Liang S, et al
    Virtual screening targeting the conserved domain of the IAV M2 protein reveals the potential broad-spectrum anti-IAV activity of ajmaline.
    Biochem Biophys Res Commun. 2026;814:153643.
    PubMed         Abstract available


    BMJ

  2. DAVIES SR, Davies AL, Higgins JPT, Caldwell DM, et al
    Effectiveness of interventions to increase vaccine uptake: component network meta-analysis.
    BMJ. 2026;393:e087578.
    PubMed         Abstract available


    Drug Saf

  3. HWANG CS, Lu Z, Russo M, Zakoul H, et al
    Physician Awareness of FDA's Relaxation of REMS-Required Laboratory Testing Requirements and Changes in Prescribing Practices During the COVID-19 Pandemic.
    Drug Saf. 2026;49:519-528.
    PubMed         Abstract available

  4. COATES MM, Rowe SL, Sullivan SG, Munoz FM, et al
    Assessing the Use of Medical Insurance Claims and Electronic Health Records to Measure COVID-19 Vaccination During Pregnancy.
    Drug Saf. 2026;49:567-580.
    PubMed         Abstract available

  5. RACHWAL O, Gutierrez-Lobon M, Cueto NS, Ventura AN, et al
    Evaluating COVID-19 Vaccine Masking and Unmasking Methods in Two National Pharmacovigilance Databases.
    Drug Saf. 2026;49:581-590.
    PubMed         Abstract available

  6. JAJOU R, van Puijenbroek E, Overbeek J, Hek K, et al
    GP Consultations for Herpes Zoster After COVID-19 Vaccination: A Self-Controlled Cohort Study Based on Electronic Health Record Data from the Netherlands.
    Drug Saf. 2026;49:529-539.
    PubMed         Abstract available


    Epidemiol Infect

  7. GONZALES BE, Ochoa TJ, van der Sande MAB
    Inequalities in complete pneumococcal vaccination among Peruvian children before and after the COVID-19 pandemic: An evaluation using demographic and health surveys from 2018 to 2023.
    Epidemiol Infect. 2026;154:e49.
    PubMed         Abstract available

  8. KIMURA M, Asai Y, Tsuzuki S, Shimizu Y, et al
    Effectiveness of voluntary PCR testing against COVID-19 spread in remote Japanese islands.
    Epidemiol Infect. 2026;154:e48.
    PubMed         Abstract available


    J Virol Methods

  9. ASGHARI M, Golalipour M, Memarian A, Farazmandfar T, et al
    Presentation of multiple copies of a non-dominant surface epitope by circular RNA effectively induce an immune response against SARS-CoV-2.
    J Virol Methods. 2026;343:115378.
    PubMed         Abstract available

  10. CHIBA S
    Therapeutic mechanisms of early oseltamivir administration in the management of mild COVID-19 through the sympathetic nervous system: A scoping review.
    J Virol Methods. 2026;343:115386.
    PubMed         Abstract available


    Lancet

  11. JOHANSEN ND, Seco JP, Martinon-Torres F, Biering-Sorensen T, et al
    Unclear benefits of higher doses of influenza vaccine - Authors' reply.
    Lancet. 2026;407:1426.
    PubMed        

  12. FLAHAULT A
    Unclear benefits of higher doses of influenza vaccine.
    Lancet. 2026;407:1425-1426.
    PubMed        


    PLoS Biol

  13. SOLA I, Zuniga S
    New transcription signals in SARS-CoV-2 reshape virus-host interactions.
    PLoS Biol. 2026;24:e3003744.
    PubMed         Abstract available


    PLoS Comput Biol

  14. JEONG YD, Hart WS, Ishikane M, Kim KS, et al
    Identifying the optimal rapid antigen test for screening and determining the end of isolation: A modeling study.
    PLoS Comput Biol. 2026;22:e1013102.
    PubMed         Abstract available

  15. ANOKYE F, Li MWZ, Walker S, Hurford A, et al
    Quantifying SARS-CoV-2 Omicron variant spread and the impact of non-pharmaceutical interventions in Newfoundland and Labrador, Canada.
    PLoS Comput Biol. 2026;22:e1013562.
    PubMed         Abstract available


    PLoS One

  16. ABDELGHANY M, Yu F, Rennard S, Gwon Y, et al
    Bayesian reanalysis of early remdesivir for the treatment of COVID-19 in outpatients with high risk of progression to severe disease.
    PLoS One. 2026;21:e0346878.
    PubMed         Abstract available

  17. BERBER E, Hanley HB, Gamez BM, Ross TM, et al
    Assessment of hemagglutinin-inhibition activity following influenza vaccination during the 2022-2023, 2023-2024, and 2024-2025 seasons.
    PLoS One. 2026;21:e0347314.
    PubMed         Abstract available

  18. MURALIDHAR K, Ngaybe MGB, Pope B, Nanjaiah S, et al
    Behavioural and Social Drivers (BeSD) of COVID-19 vaccination for children: A cross-sectional study of parental vaccine confidence and intent in Mysore, India.
    PLoS One. 2026;21:e0316877.
    PubMed         Abstract available

  19. BHUPATHI M, Hegde S, Molloy JC, Devarapu GCR, et al
    MobileLAMP: A low-cost, portable incubation device for isothermal nucleic acid amplification.
    PLoS One. 2026;21:e0346874.
    PubMed         Abstract available

  20. SHIMAZU Y, Isoda N, Hiono T, Hew YL, et al
    Evaluation of therapeutic efficacy of baloxavir marboxil against high pathogenicity avian influenza virus infection in duck model.
    PLoS One. 2026;21:e0347205.
    PubMed         Abstract available

  21. GANGAT R, Ngah V, Tawonga R, Blanford JI, et al
    Spatial and temporal patterns of SARS-CoV-2 infection in uMgungundlovu, KwaZulu-Natal, South Africa.
    PLoS One. 2026;21:e0317648.
    PubMed         Abstract available

  22. VAN DUINKERKEN A, van der Velden PG, Duckers MLA, Baliatsas C, et al
    Revisiting the exposure criterion for PTSD: Using the COVID-19 pandemic as an opportunity to assess measurement invariance of PTSD symptoms across event types.
    PLoS One. 2026;21:e0347315.
    PubMed         Abstract available

  23. KITTUR ME, Jones BDM, Imran S, Wang W, et al
    Impact of the COVID-19 pandemic on adults accessing specialist psychiatric care: A cross-sectional Canadian analysis.
    PLoS One. 2026;21:e0346913.
    PubMed         Abstract available

  24. CASJENS S, Hovanec J, Glaser N, Massag J, et al
    Occupational risk factors for depression and anxiety symptoms: Insights from a large cohort study during and after the SARS-CoV-2 pandemic.
    PLoS One. 2026;21:e0346871.
    PubMed         Abstract available

  25. JIANG KP, Bennett S, Yager P
    Heat-actuated valve implementation in a point-of-care, paper-based microfluidic device for infectious disease detection.
    PLoS One. 2026;21:e0344750.
    PubMed         Abstract available

  26. ABBAS U, Laghari RN, Ahmed I, Musawwir UA, et al
    Acute SARS-CoV-2 viral load and systemic inflammation are associated with neuropsychiatric and musculoskeletal symptoms in long COVID.
    PLoS One. 2026;21:e0346978.
    PubMed         Abstract available

  27. OZATO N, Hori S, Miyai N, Takase H, et al
    Association of visceral fat and plasmacytoid dendritic cell-derived interferon alpha with SARS-CoV-2 infection.
    PLoS One. 2026;21:e0344870.
    PubMed         Abstract available

  28. DIAS GF, Fan C, Han M, Wang X, et al
    COVID-19 in hemodialysis patients: New insights into metabolomic profile dynamics from 60 days pre- to 60 days post-diagnosis.
    PLoS One. 2026;21:e0346687.
    PubMed         Abstract available

  29. MOHTASHAM F, Hashemi Nazari SS, Pourhoseingholi MA, Kavousi K, et al
    Hybrid feature-selection and diversity-guided stacking framework for interpretable ensemble learning: Application to COVID-19 mortality prediction.
    PLoS One. 2026;21:e0341198.
    PubMed         Abstract available

  30. LEE SJ, Kim J, Han M, Lee JA, et al
    Distinct plasma cytokine and chemokine profiles in severe COVID-19 and septic shock.
    PLoS One. 2026;21:e0347126.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  31. GOLDMAN N, Pebley AR
    The Latino health experience: Past and future.
    Proc Natl Acad Sci U S A. 2026;123:e2530795123.
    PubMed         Abstract available

  32. HUOT M, Wang D, Shakhnovich E, Monasson R, et al
    Constrained evolutionary funnels shape viral immune escape.
    Proc Natl Acad Sci U S A. 2026;123:e2536956123.
    PubMed         Abstract available

  33. FARIAS A, Bridgeman VL, Rodrigues FS, Puttur F, et al
    Type I interferons induced upon respiratory viral infection impair lung metastatic initiation.
    Proc Natl Acad Sci U S A. 2026;123:e2412919123.
    PubMed         Abstract available


    Vaccine

  34. HSIEH SM, Choi MJ, Chen YC, Cheng SY, et al
    Cost-effectiveness of vaccination of older adults with an MF59(R)-adjuvanted quadrivalent influenza vaccine compared to standard-dose and high-dose vaccines in South Korea and Taiwan.
    Vaccine. 2026;80:128533.
    PubMed         Abstract available

  35. ANYALECHI EG, Marquez PL, Rubin MN, Johannsen SP, et al
    Safety of seasonal inactivated influenza vaccines in children 6 months-17 years of age in the Vaccine Adverse Events Reporting System (VAERS) 2018-2023: before, during, and after the COVID-19 pandemic public health emergency.
    Vaccine. 2026;81:128569.
    PubMed         Abstract available


    Virology

  36. SWIERKOT J, Tyczynska KM, Siemaszko J, Madej M, et al
    The association of selected genetic polymorphisms with adverse events following COVID-19 vaccination: a single-centre prospective observational cohort study.
    Virology. 2026;619:110876.
    PubMed         Abstract available

  37. CHEN G, Liang D, Liu M, Lv Z, et al
    Theaflavins suppresses RSV infection by modulating the MAVS-I-IFN pathway.
    Virology. 2026;619:110872.
    PubMed         Abstract available

  38. LIU R, Patterson L, Yeasmin M, Kim KH, et al
    Low-dose multivalent COVID-19 mRNA vaccines enhance broadly cross-reactive antibodies and protective immune responses of co-administered protein-based vaccines.
    Virology. 2026;619:110884.
    PubMed         Abstract available

  39. WANG Z, Wongnak R, Oba M, Mizutani T, et al
    Omicron RBD expressed in E. coli outperforms mammalian-expressed S1 spike protein in generating highly neutralizing anti-SARS-CoV-2 antibodies in mice.
    Virology. 2026;619:110894.
    PubMed         Abstract available

  40. RICHARDSON SAS, Boodhoo N, Bhat S, Wells J, et al
    Differential outcomes of viral co-infections with high pathogenicity avian influenza A(H5N6) and SARS-CoV-2 in mammalian in vitro systems.
    Virology. 2026;620:110912.
    PubMed         Abstract available

Saturday, April 11, 2026

#Coronavirus Disease Research #References (by AMEDEO, April 11 '26)

 


    Emerg Infect Dis

  1. NILLES EJ, Paulino CT, Vasquez M, Duke W, et al
    Acute Febrile Illness Surveillance for Estimating Population Immunity, Dominican Republic, 2021.
    Emerg Infect Dis. 2026;32.
    PubMed         Abstract available


    Infect Control Hosp Epidemiol

  2. LEUCCI AC, Sasdelli E, Caselli L, Fabbri E, et al
    Healthcare-associated infections in Italian long-term care facilities: a machine learning analysis of a 12-month cohort.
    Infect Control Hosp Epidemiol. 2026 Apr 8:1-8. doi: 10.1017/ice.2026.10413.
    PubMed         Abstract available

  3. NG I, Kave B, Paynter C, Bodas C, et al
    Speech intelligibility and hearing acuity assessments of N95/P2 respirator with under-mask elastic band beard cover.
    Infect Control Hosp Epidemiol. 2025;46:1127-1133.
    PubMed         Abstract available

  4. MILNER AL, Eckstein EC, Donskey CJ
    Does one size fit all for contact precautions implementation? Impact of requiring use of gloves and gowns for every room entry on personnel time, personal protective equipment costs, and carbon footprint.
    Infect Control Hosp Epidemiol. 2025;46:1161-1163.
    PubMed         Abstract available


    Int J Infect Dis

  5. CHOI Y, Bae GH, Jeon J, Yoon J, et al
    Short-Term Mortality and the Impact of Disability Type Following COVID-19 Among Individuals with Disabilities: A Population-Based Study.
    Int J Infect Dis. 2026 Apr 4:108677. doi: 10.1016/j.ijid.2026.108677.
    PubMed         Abstract available

  6. OGAWA K, Xu YS, Shimakawa Y, Chowell G, et al
    Secondary SARS-CoV-2 Transmission from Childcare Workers versus Teachers in School-Associated Screening Events, Okinawa, Japan, January-March 2022.
    Int J Infect Dis. 2026 Apr 2:108672. doi: 10.1016/j.ijid.2026.108672.
    PubMed         Abstract available

  7. UNSELD M, Sturtzel B, Meyer AL, Blaise M, et al
    Real-world effectiveness and antibody responses of BNT162b2 vaccination in long-term care residents: a retrospective case-control study.
    Int J Infect Dis. 2026 Apr 2:108682. doi: 10.1016/j.ijid.2026.108682.
    PubMed         Abstract available

  8. PETERSEN E, Hviid AP
    Inosine pranobex as a treatment of SARS-CoV2?
    Int J Infect Dis. 2026 Dec 31:108657. doi: 10.1016/j.ijid.2026.108657.
    PubMed        


    Intensive Care Med

  9. GODOLPHIN PJ, Fisher DJ, Bradbury CA, Murthy S, et al
    Intermediate- versus prophylactic-dose heparin for hospitalised patients with COVID-19: an updated meta-analysis of randomised trials.
    Intensive Care Med. 2026 Apr 7. doi: 10.1007/s00134-025-08128.
    PubMed        


    J Infect

  10. LOMHOLT FK, Valentiner-Branth P, Nielsen RT, Slotved HC, et al
    A real-time register-based surveillance system for non-invasive and invasive pneumococcal disease.
    J Infect. 2026 Apr 4:106744. doi: 10.1016/j.jinf.2026.106744.
    PubMed         Abstract available


    J Virol

  11. JEFFERSON V, Endlich-Frazier A, Letko M
    Exploring coronavirus cell entry with functional viromics.
    J Virol. 2026 Apr 6:e0172825. doi: 10.1128/jvi.01728.
    PubMed         Abstract available

  12. CHEN N, Kleine-Weber H, Alkharsah K, Winkler M, et al
    Q1020R in the spike proteins of MERS-CoV from Arabian camels confers resistance against soluble human DPP4.
    J Virol. 2026 Apr 6:e0028226. doi: 10.1128/jvi.00282.
    PubMed         Abstract available


    Life Sci

  13. CHEN W, Ji MC, Jung E, Shin JS, et al
    Broad-spectrum coronavirus inhibition by RSV fusion inhibitors targeting six-helix bundle formation.
    Life Sci. 2026 Mar 31:124357. doi: 10.1016/j.lfs.2026.124357.
    PubMed         Abstract available


    Science

  14. PHILLIPS KA, Horn DM, Califf RM
    Diagnostics investments and disease burden.
    Science. 2026;392:151-153.
    PubMed         Abstract available

  15. KHAN S, Zhang R, Khan A, Shah A, et al
    We survived COVID-19-Are we ready for Nipah?
    Science. 2026;392:157-158.
    PubMed        

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, April 11 '26)

 


    Biochemistry

  1. VOGET R, Gutschow M
    Early Kinetic Characterization of SARS-CoV-2 Main Protease Inhibitors: A Review and Guidance for Biochemical Assessments.
    Biochemistry. 2026;65:860-881.
    PubMed         Abstract available


    Epidemiol Infect

  2. MILLER AC, Boonstra DE, Cavanaugh JE, Boikos C, et al
    Disease burden associated with influenza activity at the population level.
    Epidemiol Infect. 2026 Apr 6:1-28. doi: 10.1017/S0950268826101320.
    PubMed        

  3. ABUNIJELA S, Greiner T, Haas W, Kerber R, et al
    Frequency, dynamics, and duration of faecal shedding in SARS-CoV-2-infected individuals, a scoping review.
    Epidemiol Infect. 2026;154:e44.
    PubMed         Abstract available


    J Exp Med

  4. MATHEW NR, Gailleton R, Scharf L, Schon K, et al
    Nasal CD4+ tissue-resident memory T cells provide cross-protective immunity to influenza.
    J Exp Med. 2026;223:e20251793.
    PubMed         Abstract available


    J Infect Dis

  5. ULANOWICZ CJ, Alarcon PC, Damen MSMA, Wayland JL, et al
    Distinct inflammatory programming of thoracic cavity white adipose immune cells regulates influenza pathogenesis.
    J Infect Dis. 2026 Apr 7:jiag201. doi: 10.1093.
    PubMed         Abstract available


    N Engl J Med

  6. PARDO-SECO J, Martinon-Torres F
    High-Dose Influenza Vaccine and Hospitalizations in Older Adults. Reply.
    N Engl J Med. 2026;394:1454.
    PubMed        

  7. JOHANSEN ND, Biering-Sorensen T
    High-Dose Influenza Vaccine and Hospitalizations in Older Adults. Reply.
    N Engl J Med. 2026;394:1454.
    PubMed        

  8. KANEDA Y, Fujikawa T
    High-Dose Influenza Vaccine and Hospitalizations in Older Adults.
    N Engl J Med. 2026;394:1453-1454.
    PubMed        

  9. CHEN HY, Liao JC, Yong SB
    High-Dose Influenza Vaccine and Hospitalizations in Older Adults.
    N Engl J Med. 2026;394:1453.
    PubMed        


    Pediatrics

  10. OLSON SM, Ahmad HM, Wielgosz K, Michaels MG, et al
    Pediatric Vaccine Effectiveness Against Influenza Hospitalization And Outpatient Visits: 2021-2024.
    Pediatrics. 2026 Apr 6:e2025073973. doi: 10.1542/peds.2025-073973.
    PubMed         Abstract available

  11. LUCACCIONI H, Maurel M, Perez-Gimeno G, Buda S, et al
    Influenza Vaccine Effectiveness in European Primary Care Pediatric Practices: 2022-2024.
    Pediatrics. 2026 Apr 6:e2025072907. doi: 10.1542/peds.2025-072907.
    PubMed         Abstract available


    PLoS One

  12. ANTAO V, Krueger P, Meaney C, Kwong JC, et al
    Predictors of burnout among academic family medicine faculty: Looking back to plan forward.
    PLoS One. 2026;21:e0344702.
    PubMed         Abstract available

  13. SPINOS D, Beech T, Lee J, Coulson C, et al
    Referral to treatment times in the National Health Service of England: A five-year analysis of the impact of the COVID-19 Pandemic and socioeconomic deprivation and future implications for Ear, Nose and Throat service delivery.
    PLoS One. 2026;21:e0346596.
    PubMed         Abstract available

  14. SHARBAYTA SS, Jo Y, Jung J, Buonomo B, et al
    The impact of human behavioral adaptation stratified by immune status on COVID-19 spread with application to South Korea.
    PLoS One. 2026;21:e0345642.
    PubMed         Abstract available

  15. GRAFF I, Berger M, Schmid M, Kogej M, et al
    A decade of triage with the Manchester Triage System-The MTS big data study.
    PLoS One. 2026;21:e0344598.
    PubMed         Abstract available

  16. FELLER RL, Narraway CL, Burslem DF, Colucci-Gray L, et al
    Private garden uses and associated mental well-being benefits during the first UK Covid-19 lockdown - a social media investigation.
    PLoS One. 2026;21:e0289446.
    PubMed         Abstract available

  17. PAN C, Shen W
    Revisiting price linkages between London and Shanghai base metal futures markets: A time-frequency connectedness analysis.
    PLoS One. 2026;21:e0346602.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  18. HA J, Sharma P, Ta S, Tsukuda S, et al
    Hypoxia inducible factors regulate pneumovirus replication by enhancing innate immune sensing.
    Proc Natl Acad Sci U S A. 2026;123:e2506647123.
    PubMed         Abstract available

  19. PARENTI NA, Cusic R, Renner DM, Jackson N, et al
    SARS-CoV-2 and MERS-CoV disrupt host protein synthesis via nsp1 with differential effects on the integrated stress response.
    Proc Natl Acad Sci U S A. 2026;123:e2536296123.
    PubMed         Abstract available


    Vaccine

  20. MCCULLOUGH R, Reid A, Smyth D, O'Neill MT, et al
    Leadership matters: ward manager vaccination status influences nursing staff influenza vaccine uptake.
    Vaccine. 2026;80:128541.
    PubMed         Abstract available

  21. ZHANG J, Gong C, Xu Z, Han R, et al
    Multi-mode spatial accessibility to vaccination services and its impact on influenza-related hospitalisations among older adults.
    Vaccine. 2026;80:128540.
    PubMed         Abstract available


    Virus Res

  22. WU Y, Sun W, Xia Y, Feng Y, et al
    The influenza B virus candidate vaccine expressing H3 hemagglutinin developed in suspension MDCK cells confers protection against lethal H3N2 avian influenza in BALB/c mice.
    Virus Res. 2026;367:199722.
    PubMed         Abstract available

Saturday, April 4, 2026

#Coronavirus Disease Research #References (by AMEDEO, April 4 '26)

 


    Ann Intern Med

  1. REIS G, Dos Santos Moreira Silva EA, Medeiros Silva DC, Thabane L, et al
    The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID : An Adaptive Randomized Trial.
    Ann Intern Med. 2026 Mar 31. doi: 10.7326/ANNALS-25-03959.
    PubMed         Abstract available


    Clin Infect Dis

  2. NADIG N, Bhimraj A, Cawcutt K, Chiotos K, et al
    2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. Tocilizumab.
    Clin Infect Dis. 2026 Apr 1:ciaf681. doi: 10.1093.
    PubMed         Abstract available

  3. SHUMAKER AH, Bhimraj A, Bedimo R, Cheng VC, et al
    2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in Adults.
    Clin Infect Dis. 2026 Apr 1:ciaf680. doi: 10.1093.
    PubMed         Abstract available


    Int J Infect Dis

  4. HOSSAIN MS, Goyal R, Martin NK, DeGruttola V, et al
    Machine Learning and Probabilistic Approaches for Forecasting Infectious Disease Transmission and Cases.
    Int J Infect Dis. 2026 Mar 30:108674. doi: 10.1016/j.ijid.2026.108674.
    PubMed         Abstract available

  5. VESELY D, Capek V, Sanca O, Beran J, et al
    Inosine pranobex was associated with a reduction in mortality in COVID-19 by over 22%, as reported in a retrospective study utilizing complete health data from the Czech national registry.
    Int J Infect Dis. 2026 Dec 31:108519. doi: 10.1016/j.ijid.2026.108519.
    PubMed         Abstract available


    J Med Virol

  6. GARCIA-VILLALBA J, Hurtado-Navarro L, Angosto-Bazarra D, Baroja-Mazo A, et al
    The Open Reading Frame 7b of the SARS-CoV-2 Disperse Trans-Golgi and Activate the NLRP3 Inflammasome.
    J Med Virol. 2026;98:e70894.
    PubMed         Abstract available

  7. THEO CH, Sam IC, Chan YF
    The Diverse Roles of Heparan Sulfate in RNA Virus Infections: Insights From Enterovirus A71, Severe Acute Respiratory Syndrome Coronavirus 2, and Chikungunya Virus.
    J Med Virol. 2026;98:e70888.
    PubMed         Abstract available


    J Virol

  8. MOU C, Liu M, Xiang Y, Lin C, et al
    SADS-CoV NS3 induces apoptosis by blocking the formation of Bcl-xL-BAK complex.
    J Virol. 2026 Mar 31:e0021626. doi: 10.1128/jvi.00216.
    PubMed         Abstract available

  9. KONG W, Zhang J, Song Y, Song J, et al
    Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    J Virol. 2026 Mar 30:e0027026. doi: 10.1128/jvi.00270.
    PubMed         Abstract available

  10. GUO X, Zhao X, He J, Lu Y, et al
    E3 ubiquitin ligase NEDD4 inhibits PEDV infection through ubiquitination and degradation of the viral primase NSP8.
    J Virol. 2026 Mar 30:e0215625. doi: 10.1128/jvi.02156.
    PubMed         Abstract available

  11. XIU R, Wang Y, Cai W, Wang Q, et al
    Potent in vitro synergistic antiviral effects of the pan-coronavirus fusion inhibitor EK1 in combination with RBD-specific antibodies or M(pro) inhibitors.
    J Virol. 2026 Mar 30:e0007626. doi: 10.1128/jvi.00076.
    PubMed         Abstract available

  12. CHENG D, Luo Z, Ning W, Heath SL, et al
    Systemic translocation of Staphylococcus aureus promotes autoimmunity: implications in autoantibody-mediated poor immune reconstitution from antiretroviral therapy in HIV.
    J Virol. 2026 Apr 3:e0196525. doi: 10.1128/jvi.01965.
    PubMed         Abstract available

  13. POZHIDAEVA A, Hoch JC, Pustovalova Y
    The DMV pore-forming TM2-Y region of SARS-CoV-2 nsp3 exhibits structural conservation beyond the coronavirus family.
    J Virol. 2026 Apr 3:e0203825. doi: 10.1128/jvi.02038.
    PubMed         Abstract available


    JAMA

  14. ANDERER S
    US COVID-19 Deaths May Have Been Underreported, Study Finds.
    JAMA. 2026 Apr 3. doi: 10.1001/jama.2026.1032.
    PubMed        


    Lancet Infect Dis

  15. CAMICI M, Piano Mortari E, Del Duca G, Cimini E, et al
    Intravenous immunoglobulin treatment for long COVID: a case report of clinical and immunological findings.
    Lancet Infect Dis. 2026 Mar 31:S1473-3099(26)00063.
    PubMed         Abstract available

  16. WALKER MK, Yek C, Sarzynski S, Warner S, et al
    Survival trends in patients with difficult-to-treat, antibiotic-resistant, Gram-negative infections in the era of next-generation antibiotics in the USA: a retrospective cohort study.
    Lancet Infect Dis. 2026 Mar 25:S1473-3099(26)00020.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  17. MEGHANI M, Garacci Z, Razzaghi H, de Perio MA, et al
    Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel - United States, 2024-25 Respiratory Virus Season.
    MMWR Morb Mortal Wkly Rep. 2026;75:164-171.
    PubMed         Abstract available


    Science

  18. STONE R
    U.S. blockade hits Cuba's health care and science.
    Science. 2026;392:8-9.
    PubMed         Abstract available

  19. FAN Q, Mei J, Li T, Zang C, et al
    A high-throughput selection system for fast-acting covalent protein drugs.
    Science. 2026 Apr 2:eadv3081. doi: 10.1126/science.adv3081.
    PubMed         Abstract available

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, April 4 '26)

 


    Antimicrob Agents Chemother

  1. VETTER P, Cabecinhas ARG, Schibler M, Kaiser L, et al
    Use of baloxavir as adjunctive antiviral therapy to neuraminidase inhibitors in severely immunocompromised individuals infected with influenza.
    Antimicrob Agents Chemother. 2026 Mar 27:e0165925. doi: 10.1128/aac.01659.
    PubMed         Abstract available


    J Infect Dis

  2. HUNT JH, Damhorst GL, Parsons R, Frediani JK, et al
    Peak Nasal SARS-CoV-2 and Influenza Viral Loads Relative to Symptom Onset, 2022-2025: Impact of Vaccination and Implications for Multiplexed Testing.
    J Infect Dis. 2026 Apr 1:jiag169. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  3. KIM K-H, Hwang HS, Pal SS, Tien Le CT, et al
    Type I interferon signaling is required for resistance to primary influenza virus infection and vaccine-induced long-term immunity.
    J Virol. 2026 Mar 27:e0022926. doi: 10.1128/jvi.00229.
    PubMed         Abstract available

  4. CIACCI ZANELLA G, Cardenas MI, Hutter CR, Snyder CA, et al
    Impact of maternal antibodies and weaning stress on the replication and transmission of human H3N2 influenza A in piglets.
    J Virol. 2026 Mar 27:e0197525. doi: 10.1128/jvi.01975.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  5. MEGHANI M, Garacci Z, Razzaghi H, de Perio MA, et al
    Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel - United States, 2024-25 Respiratory Virus Season.
    MMWR Morb Mortal Wkly Rep. 2026;75:164-171.
    PubMed         Abstract available


    PLoS Biol

  6. MULLOY RP, Evseev D, Sharlin N, Bui-Marinos MP, et al
    Evolution of a truncated nucleocapsid protein enhances SARS-CoV-2 fitness by suppressing antiviral responses.
    PLoS Biol. 2026;24:e3003646.
    PubMed         Abstract available


    PLoS Comput Biol

  7. GANGWAR P, Katte P, Bhat M, Turakhia Y, et al
    WEPP: Phylogenetic placement achieves near-haplotype resolution in wastewater-based epidemiology.
    PLoS Comput Biol. 2026;22:e1014124.
    PubMed         Abstract available

  8. ORSINELLI-RIVERS S, Beaglehole D, Einav T
    CAPYBARA: A generalizable framework for predicting serological measurements across human cohorts.
    PLoS Comput Biol. 2026;22:e1014129.
    PubMed         Abstract available


    PLoS Med

  9. XIAO H, Bai G, Liu F, Cui Y, et al
    Policy stringency during the COVID-19 pandemic and healthcare services utilization in China: An interrupted time-series analysis.
    PLoS Med. 2026;23:e1004672.
    PubMed         Abstract available


    PLoS One

  10. BRAUN J, Hill ED, Contreras E, Yasuda M, et al
    Contrasting effects of SARS-CoV-2 vaccination vs. infection on antibody and TCR repertoires.
    PLoS One. 2026;21:e0343939.
    PubMed         Abstract available

  11. ADYNSKI GI, Dictus C, Adynski H, Killela MK, et al
    Experiences of registered nurses and nursing assistants during COVID-19: Work stress, stress appraisal, and workplace resources; A qualitative descriptive study.
    PLoS One. 2026;21:e0345525.
    PubMed         Abstract available

  12. BORBOR-CORDOVA MJ, Searles M, Roa-Lopez H, Cornejo-Rodriguez MDP, et al
    Integrating psychosocial health into disaster risk management: Insights from COVID-19 in Duran, Ecuador.
    PLoS One. 2026;21:e0343239.
    PubMed         Abstract available

  13. HASSAN M, Iqbal MS, Yasir M, Chun W, et al
    Assessment of miRNAs as transcriptional regulators in respiratory syncytial virus infection through computational analysis and molecular docking studies.
    PLoS One. 2026;21:e0345571.
    PubMed         Abstract available

  14. NAKAZATO T, Romani-Romani F, Gutierrez C
    Screen time and chronic neck pain in Peru: A comparative population-based cross-sectional study in the COVID-19 post-pandemic period.
    PLoS One. 2026;21:e0344257.
    PubMed         Abstract available

  15. PARK H, Miyano S
    Network-constrained Random Lasso for biologically interpretable gene network inference across unequal sample sizes.
    PLoS One. 2026;21:e0344198.
    PubMed         Abstract available

  16. USAMA M, Azeem M, Mustafa G
    Computational prediction of binding affinity and structural impact of three Pakistani SARS-CoV-2 spike RBD variants on human ACE2 interaction.
    PLoS One. 2026;21:e0346242.
    PubMed         Abstract available

  17. KIM SY, Kim G, Park S, Kim C, et al
    Voting intentions during the later stage of the COVID-19 pandemic: The roles of risk perception and performance evaluations in South Korea.
    PLoS One. 2026;21:e0345621.
    PubMed         Abstract available

  18. CHUEMCHIT M, Linn N, Han CPP, Lynn Z, et al
    Violence against women migrant workers in Thailand: A cross-sectional study on experiences, impact, and help seeking.
    PLoS One. 2026;21:e0345790.
    PubMed         Abstract available

  19. WONG KH, Pandya N, McCollum S, Shabanova V, et al
    Language barriers in pediatric food allergy care: A single-center study on healthcare disparities.
    PLoS One. 2026;21:e0346248.
    PubMed         Abstract available

  20. VELTHUIJS ELM, Ismail I, de Leeuw RA, Hehenkamp WJK, et al
    Evaluating patient harm minimization during the COVID-19-driven reduction in benign gynecological care: a nationwide claims-based longitudinal study in the Netherlands.
    PLoS One. 2026;21:e0345619.
    PubMed         Abstract available

  21. RODRIGUEZ LIMA DR, Molano-Gonzalez N, Vargas Villanueva A, Pinilla Rojas DI, et al
    Mechanical ventilation as an independent risk factor for mortality in COVID-19-related ARDS: A secondary analysis using propensity score weighting.
    PLoS One. 2026;21:e0344866.
    PubMed         Abstract available

  22. LESTARI BW, Alifia A, Karnawati PWW, Ramadhani NS, et al
    Assessment of post-pandemic NAAT-based diagnostic capacity among laboratories with COVID-19 testing resource investments in Indonesia.
    PLoS One. 2026;21:e0343628.
    PubMed         Abstract available

  23. BECK WELLS M
    Disciplinary removal patterns among students with other health impairments and emotional disturbance: A three-year descriptive analysis of IDEA Part B data.
    PLoS One. 2026;21:e0346338.
    PubMed         Abstract available

  24. HASEEB MW, Toutounji M
    Non-markovian electron tunneling in SARS-CoV-2 virus infection in structured environments.
    PLoS One. 2026;21:e0344447.
    PubMed         Abstract available

  25. IUNES FM, Aranha Rossi T, Soares F, Torres TS, et al
    Factors associated with COVID-19 vaccination schedule completion among adults in high-social-vulnerability neighborhoods in two Brazilian state capitals: A cross-sectional study.
    PLoS One. 2026;21:e0346091.
    PubMed         Abstract available

  26. RIBEIRO NM, Alexandre d'Auria de Lima MCR, Monroe AA, Vinci ALT, et al
    Health and social policies to advance Brazil's End TB agenda during and after COVID-19: An analysis from tripartite governance and normative innovation perspectives.
    PLoS One. 2026;21:e0345867.
    PubMed         Abstract available

  27. STANDEN C, Tordjmann E, Wood J, Haigh F, et al
    Associations between area-level socioeconomic disadvantage and COVID-19 disease consequences in Sydney, Australia: A retrospective cohort analysis.
    PLoS One. 2026;21:e0334206.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  28. CORELL-ESCUIN P, Belmonte-Ballester S, Adhav A, Marina A, et al
    Dermcidin has antiviral activity and protects against influenza.
    Proc Natl Acad Sci U S A. 2026;123:e2424461123.
    PubMed         Abstract available


    Vaccine

  29. CHAN CP, Wong NS, Lee SS
    Normalising enhanced influenza vaccines as a strategy to promote vaccination uptake in healthcare workers: Insights from a discrete choice experiment.
    Vaccine. 2026;80:128539.
    PubMed         Abstract available

  30. PODER A, Trinidad-Aseron M, Van Twuijver E, Versage E, et al
    Immunogenicity and safety of MF59-adjuvanted H5N1 pandemic influenza vaccine in healthy infants and children: a phase 2 randomized, observer-blind, multicenter study.
    Vaccine. 2026;80:128504.
    PubMed         Abstract available

  31. TSCHERNE A, Krammer F
    Seven decades after the Asian influenza pandemic: A historical review about immunity and vaccines against H2N2.
    Vaccine. 2026;79:128467.
    PubMed         Abstract available

  32. VAN TRUONG L, Van Nguyen T, Trang VTT, Le TTT, et al
    Determinants of COVID-19 vaccine hesitancy across 186 countries: a multifaceted analysis using structural equation modeling.
    Vaccine. 2026;78:128196.
    PubMed         Abstract available

  33. PHIJFFER EWEM, Sivakumar C, van den Hoogen A, Crombag NMTH, et al
    Preferences of Dutch pregnant women for RSV immunisation - a mixed method study.
    Vaccine. 2026;78:128409.
    PubMed         Abstract available

  34. WANG X, Patel C, Sharma K, Giles ML, et al
    Immunisation against vaccine-preventable diseases in individuals receiving immunosuppressive targeted therapies.
    Vaccine. 2026;78:128399.
    PubMed         Abstract available

  35. RUIZ-PALACIOS GM, Cahn PE, Halperin SA, Wang R, et al
    Adenovirus type 5 vector-based COVID-19 vaccine does not increase the likelihood of HIV infection.
    Vaccine. 2026;78:128378.
    PubMed         Abstract available

  36. LYONS AJ, Mhatre MM, Argenio K, Day S, et al
    Does human papillomavirus vaccination status differ by disability status in New York city public schools?
    Vaccine. 2026;78:128404.
    PubMed         Abstract available

  37. SABATE M, Riera-Arnau J, Ballarin E, Pares-Badell O, et al
    Validation of Guillain-Barre syndrome case identification in three heterogeneous VAC4EU real-world data sources in Spain using the Brighton Collaboration criteria.
    Vaccine. 2026;78:128397.
    PubMed         Abstract available


    Virology

  38. RAMUTH M, Sonoo J, Pyndiah N, Rughooputh S, et al
    Epidemiology of influenza A and B viruses in Mauritius over an 8-year period, 2009-2016.
    Virology. 2026;619:110892.
    PubMed         Abstract available

My New Space

Most Popular Posts